Category: Drug Approvals

Home / Drug Approvals

Categories

Utilization of wearable telehealth technology for remote patient monitoring is validated by new Sheba medical center study

July 2022: Peer-reviewed study analyzes usability of a wearable RPM device, which detected early warning of risk for ABCNO deterioration in 75% of patients, 38 hours on average before actual cl...

Best cancer hospitals in India in 2023

Here's the list of the best cancer hospitals in India:. The list is very carefully prepared, keeping in mind the use of the latest technology to treat cancer, ongoing research projects in the hospita...

Selpercatinib is approved by FDA for locally advanced or metastatic RET fusion-positive solid tumors

November 2022: Selpercatinib (Retevmo, Eli Lilly and Company) received accelerated approval from the Food and Drug Administration to treat adult patients with RET-fused solid tumours that are locally ...

Sodium thiosulfate is approved by FDA to reduce the risk of ototoxicity associated with cisplatin in pediatric patients with localized, non-metastatic solid tumors

November 2022: In children aged one month and older with localised, non-metastatic solid tumours, the Food and Drug Administration has approved sodium thiosulfate (Pedmark, Fennec Pharmaceuticals Inc....

Durvalumab is approved for locally advanced or metastatic biliary tract cancer

November 2022: For adult patients with locally advanced or metastatic biliary tract cancer, the Food and Drug Administration has approved durvalumab (Imfinzi, AstraZeneca UK Limited) in combination wi...

Claudin 18.2 and its role in advanced gastric cancers

August 2022: The most apical portion of polarized epithelial and endothelial cells contains tight junctions, which are specialized membrane domains. The claudins, which are important proteins in tigh...

Crizotinib is approved by FDA for ALK-positive inflammatory myofibroblastic tumor

 July 2022: Crizotinib (Xalkori, Pfizer Inc.) was granted approval by the Food and Drug Administration (FDA) for the treatment of adult and paediatric patients 1 year of age and older who were diagn...

Dabrafenib in combination with trametinib is approved by FDA for unresectable or metastatic solid tumors with BRAF V600E mutation

July 2022: Dabrafenib (Tafinlar, Novartis) and trametinib (Mekinist, Novartis) received accelerated approval from the Food and Drug Administration for the treatment of adult and paediatric patients ol...

Opdivo in combination with chemotherapy and Opdivo in combination with Yervoy is approved by FDA for first-line esophageal squamous cell carcinoma indications

June 2022: For the first-line therapy of individuals with advanced or metastatic esophageal squamous cell carcinoma (ESCC), the Food and Drug Administration has approved the following: In combinat...

World Cancer Day 2022

4th Feb 2022: In India, cancer can have serious social and economic effects, typically resulting in family destitution and societal injustice. In this demographically young country, reported age-adjus...

Scan the code